Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 192
- 主要终点
- Change From Baseline in Mean Worse Eye Intraocular Pressure (IOP) at Week 12
研究概览
简要总结
This study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ocular hypertension or primary open-angle glaucoma in each eye
- •Requires treatment with IOP-lowering medication in both eyes
排除标准
- •Required chronic use of ocular medications during the study other than study medication
- •Use of any corticosteroids within 30 days
- •History of any prior eye surgery, except for uncomplicated eye surgery performed more than 6 months before the Screening visit
- •Anticipated wearing of contact lenses during the study
研究组 & 干预措施
Triple Combination Therapy
Triple Combination Therapy with bimatoprost/brimonidine tartrate/timolol ophthalmic solution. One drop of Triple Combination Therapy administered to each eye, twice daily for 12 weeks.
干预措施: bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy) (Drug)
Combigan®
Fixed Combination brimonidine tartrate/timolol ophthalmic solution (Combigan®). One drop of Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution administered to each eye, twice daily for 12 weeks.
干预措施: Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution (Drug)
结局指标
主要结局
Change From Baseline in Mean Worse Eye Intraocular Pressure (IOP) at Week 12
时间窗: Baseline, Week 12
IOP is a measurement of the fluid pressure inside the eye. For each eye, the IOP was either the average of 2 measurements, or, if a third measurement was required, the median of the 3 measurements. The worse eye was determined based on the IOP results at Baseline. The mean worse eye IOP was the average of the IOP measurements of the worse eye at hours 0 and 2 at week 12. A negative change from Baseline indicated improvement.
次要结局
- Mean Worse Eye IOP(Weeks 1, 2, 4, 8 and 12)
- Change From Baseline in Mean Worse Eye IOP(Baseline, Weeks 1, 2, 4 and 8)